Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion type Assertion NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_head.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion description "[TRPM2 seems to be a candidate for gene therapy in glioblastoma cells, since the insertion of TRPM2 into A172 cells can facilitate cell death through Ca2+ increase after H2O2 treatment without increasing malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion evidence source_evidence_literature NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion SIO_000772 18225560 NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion wasDerivedFrom befree-20150227 NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion wasGeneratedBy ECO_0000203 NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.